Rolls-Royce Holdings plc Total Voting Rights (3372T)

TIDMRR.

RNS Number : 3372T

Rolls-Royce Holdings plc

19 March 2019

Rolls-Royce Holdings plc ("the Company")

19 March 2019

Voting Rights and Capital

On Thursday 14 March 2019, the Company announced that application had been made to the UK Listing Authority for the listing of, and to the London Stock Exchange for the admission of 8,681,110 ordinary shares of 20p each fully paid, ranking pari passu with the existing ordinary shares, to the official list.

Admission of these shares became effective on 19 March 2019.

In accordance with DTR 5.6.1 of the FCA's Disclosure Guidance and Transparency Rules (DTR), the Company notifies the market that, as at 11 a.m. on 19 March 2019, the issued share capital of the Company is comprised of the following:-

   --    1,904,497,346 ordinary shares of 20p each with voting rights. 
   --    1 Special Rights non-voting share of GBP1 with no voting rights. 

-- 29,410,313,340 non-cumulative redeemable preference shares of 0.1p each (C Shares) with no voting rights except at any general meeting at which a resolution to wind up the Company is to be considered in which case the holders of C Shares shall have the right to attend the general meeting and shall be entitled to speak and vote only on such resolution.

None of the ordinary shares or C Shares are held in Treasury.

Therefore, the total number of voting rights in the Company is 1,904,497,346 and may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Name of contact and telephone number for queries:

Georgios Chatzopoulos - Corporate Governance Assistant

Tel: [phone]

Email notifications: [e-mail] or [e-mail]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

TVREALDNFEFNEFF

(END) Dow Jones Newswires

March 19, 2019 10:04 ET (14:04 GMT)